Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics ), By Disease Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published by Coherent Market Insights Product code 942010
Published Content info 183 Pages
Delivery time: 2-3 business days
Price
Back to Top
Diabetes Devices and Drugs Market, By Category (Diagnosis and Monitoring, Therapeutics ), By Disease Type, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Published: May 20, 2020 Content info: 183 Pages
Description

Title:
Diabetes Devices and Drugs (Diagnosis, Monitoring, and Therapeutics) Market, By Category (Diagnosis and Monitoring (Blood Glucose Monitoring Devices, Other Testing Devices, Software Programs for Diabetes Monitoring, Artificial Pancreas), Therapeutics (Insulin, Insulin Delivery, Oral Hypoglycemic Agents, Cell Therapies)), By Disease Type (Type 2 Diabetes, Type 1 Diabetes), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Diabetes devices and drugs (diagnosis, monitoring and therapeutics) consists of diabetes management right from diagnosis, monitoring, till treatment. Diabetes is characterized by high presence of blood glucose, also called blood sugar, in the body. There are three main types of diabetes: type 1, type 2, and gestational diabetes. Oral glucose tolerance testing and hemoglobin A1c (HbA1c) testing are some of the tests used in the diagnosis of the chronic condition. Treatment options include use of insulin, oral hypoglycemic agents, and others.

Restraints of the Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market

Lack of awareness about diabetes diagnostics and treatment, especially in emerging economies, is expected to hinder growth of the global diabetes devices and drugs (diagnosis, monitoring, and therapeutics) market. Moreover, recall of diabetes drugs is also expected to limit growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020-2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Abbott Laboratories, Bristol-Myers Squibb, DexCom, Inc., Eli Lilly and Company, Companion Medical, GlaxoSmithKline plc, Glenmark Pharmaceuticals, Johnson & Johnson, Lupin Ltd., F. Hoffmann-La Roche AG, and Sanofi.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global diabetes devices and drugs (diagnosis, monitoring and therapeutics) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category:
    • Diagnosis and Monitoring
  • Blood Glucose Monitoring Devices
  • Other Testing Devices
  • Software Programs for Diabetes Monitoring
  • Artificial Pancreas
    • Therapeutics
  • Insulin
  • Insulin Delivery
  • Oral Hypoglycemic Agents
  • Cell Therapies
  • Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type:
    • Type 2 Diabetes
    • Type 1 Diabetes
  • Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Geography:
    • North America
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • U.S.
    • Canada
    • Europe
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East:
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country:
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • By Category
    • Diagnosis and Monitoring
      • Blood Glucose Monitoring Devices
      • Other Testing Devices
      • Software Programs for Diabetes Monitoring
      • Artificial Pancreas
    • Therapeutics
      • Insulin
      • Insulin Delivery
      • Oral Hypoglycemic Agents
      • Cell Therapies
  • By Disease Type
    • Type 2 Diabetes
    • Type 1 Diabetes
  • By Country/Region:
    • Central Africa
    • South Africa
    • North Africa
  • Company Profiles
    • Abbott Laboratories *
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
    • Bristol-Myers Squibb
    • DexCom, Inc.
    • Eli Lilly and Company
    • Companion Medical
    • GlaxoSmithKline plc
    • Glenmark Pharmaceuticals
    • Johnson & Johnson
    • Lupin Ltd.
    • F. Hoffmann-La Roche AG
    • Sanofi

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
  • Market Definition and Scope
    • Executive Summary
  • Market Snippet, By Category
  • Market Snippet, By Disease Type
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis

4. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Category, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Diagnosis and Monitoring
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Blood Glucose Monitoring Devices
    • Other Testing Devices
    • Software Programs for Diabetes Monitoring
    • Artificial Pancreas
    • Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Insulin
    • Insulin Delivery
    • Oral Hypoglycemic Agents
    • Cell Therapies

5. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Disease Type, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • Type 2 Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
    • Type 1 Diabetes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

6. Global Diabetes Devices and Drugs (Diagnosis, Monitoring and Therapeutics) Market, By Regions, 2019 - 2027 (US$ Mn)

    • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
    • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.S.
    • Canada
    • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
    • North Africa
    • Central Africa
    • South Africa

7. Competitive Landscape

    • Company Profiles
  • Abbott Laboratories
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bristol-Myers Squibb
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DexCom, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Eli Lilly and Company
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Companion Medical
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline plc
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Glenmark Pharmaceuticals
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Johnson & Johnson
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lupin Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche AG
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

8. Section

    • References
    • Research Methodology
    • About us and Sales Contact
Back to Top